Brief: AcelRx Pharmaceuticals Announces Publication Of Results From An Investigator-Initiated Trial On Sufentanil Sublingual Tablet (SST) Compared To Standard Intravenous Opioids During Plastic Surgery Procedures Performed Under General Anesthesia
10/05/2022 14:20
May 10 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS ANNOUNCES PUBLICATION OF RESULTS
FROM AN
INVESTIGATOR-INITIATED TRIAL ON SUFENTANIL SUBLINGUAL TABLET
(SST) COMPARED TO STANDARD INTRAVENOUS OPIOIDS DURING PLASTIC
SURGERY PROCEDURES PERFORMED UNDER GENERAL ANESTHESIA
Source text for Eikon: ID:nPn1bbYBqa
Further company coverage: ACRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial